Cargando…
Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is the most severe disorder within the spectrum of motor neuron diseases (MND) that has no effective treatment and a progressively fatal outcome. We have conducted two clinical trials to assess the safety and feasibility of intravenous (IV) and intrathe...
Autores principales: | Nabavi, Seyed Massood, Arab, Leila, Jarooghi, Neda, Bolurieh, Tina, Abbasi, Fatemeh, Mardpour, Soura, Azimyian, Vajihe, Moeininia, Fatemeh, Maroufizadeh, Saman, Sanjari, Leila, Hosseini, Seyedeh Esmat, Aghdami, Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099146/ https://www.ncbi.nlm.nih.gov/pubmed/30124008 http://dx.doi.org/10.22074/cellj.2019.5370 |
Ejemplares similares
-
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal
Stromal Cells in Amyotrophic Lateral Sclerosis Patients,
Single-Center, Prospective, Open-Label, Single-Arm
Clinical Trial, Long-Term Follow-up
por: Nabavi, Seyed Massood, et al.
Publicado: (2021) -
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
por: Makhlough, Atieh, et al.
Publicado: (2017) -
Mesenchymal Stromal Cells Implantation in Combination
with Platelet Lysate Product Is Safe for Reconstruction
of Human Long Bone Nonunion
por: Labibzadeh, Narges, et al.
Publicado: (2016) -
Percutaneous Autologous Bone Marrow-Derived Mesenchymal
Stromal Cell Implantation Is Safe for Reconstruction of
Human Lower Limb Long Bone Atrophic Nonunion
por: Emadedin, Mohsen, et al.
Publicado: (2017) -
Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal
Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I
por: Bajouri, Amir, et al.
Publicado: (2023)